MARKET

AKTX

AKTX

Akari Therapeutics Plc
NASDAQ
2.400
+0.028
+1.19%
Opening 10:18 02/27 EST
OPEN
2.300
PREV CLOSE
2.372
HIGH
2.400
LOW
2.300
VOLUME
816
TURNOVER
0
52 WEEK HIGH
7.60
52 WEEK LOW
2.100
MARKET CAP
13.57M
P/E (TTM)
-0.4221
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AKTX last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at AKTX last week (0212-0216)?
Weekly Report · 02/19 10:06
Weekly Report: what happened at AKTX last week (0205-0209)?
Weekly Report · 02/12 10:01
Weekly Report: what happened at AKTX last week (0129-0202)?
Weekly Report · 02/05 10:05
Weekly Report: what happened at AKTX last week (0122-0126)?
Weekly Report · 01/29 10:00
Weekly Report: what happened at AKTX last week (0115-0119)?
Weekly Report · 01/22 10:02
Weekly Report: what happened at AKTX last week (0108-0112)?
Weekly Report · 01/15 10:00
Weekly Report: what happened at AKTX last week (0101-0105)?
Weekly Report · 01/08 10:02
More
About AKTX
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). The Company has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the United States Food and Drug Administration (FDA) for nomacopan for the treatment of pediatric HSCT-TMA. Additionally, the Company has a pre-clinical program developing long-acting PASylated-nomacopan (PAS-nomacopan) for treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD).

Webull offers Akari Therapeutics PLC (ADR) stock information, including NASDAQ: AKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKTX stock methods without spending real money on the virtual paper trading platform.